Wiley Blackwell

SHERPA: Unknown

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Bajorin
    Bajorin
  4. Solit
    Solit
  5. Morris
    Morris
  6. Voss
    Voss
  7. Bosl
    Bosl
  8. Feldman
    Feldman
  9. Rosenberg
    Rosenberg
  10. Russo
    Russo

Groups

  1. Genitourinary Oncology Service (270)
  2. Solid Tumor Oncology Division (270)
  3. Department of Medicine (269)
  4. Surgery (63)
  5. GSK Faculty (60)
  6. Urology (54)
  7. Survivorship Research (51)
  8. Department of Pathology and Laboratory Medicine (48)
  9. Human Oncology and Pathogenesis Program (43)
  10. Epidemiology and Biostatistics (40)
Search Within
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (188)
  2. Meeting Abstract (71)
  3. Guidelines (3)
  4. Review (3)
  5. Editorial (2)
  6. Book Section (1)
  7. Correspondence (1)
  8. Research Letter (1)
Groups
  1. Genitourinary Oncology Service (270)
  2. Solid Tumor Oncology Division (270)
  3. Department of Medicine (269)
  4. Surgery (63)
  5. GSK Faculty (60)
  6. Urology (54)

More Groups

People
  1. Robert Motzer (87)
  2. Howard Scher (46)
  3. Dean Bajorin (40)
  4. David Solit (25)
  5. Michael Morris (24)
  6. Martin Voss (22)

More People

Years
  1. 2025 (6)
  2. 2024 (4)
  3. 2023 (8)
  4. 2022 (11)
  5. 2021 (9)
  6. 2020 (16)

More Years

Publications
  1. Cancer (125)
  2. BJU International (72)
  3. Asia-Pacific Journal of Clinical Oncology (16)
  4. Cancer Medicine (11)
  5. Journal of Magnetic Resonance Imaging (8)
  6. Journal of Pathology (6)

More Publications

Results (270)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of population pharmacogenomics on cisplatin-induced neurotoxicities in testicular cancer survivors
    Journal Article

    Nakshatri, S.; Dinh, P. C. Jr; Einhorn, L. H.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Fung, C.; Kollmannsberger, C.; Huddart, R. A.; Travis, L. B.; more...
    Cancer Medicine (2025)

    Fulltext@MSK | Save
  • Impact of tumor burden at progression and changes in risk scores from baseline in patients with advanced renal cell carcinoma treated with lenvatinib + pembrolizumab: Phase 3 CLEAR trial
    Meeting Abstract

    Grünwald, V.; Keizman, D.; Bedke, J.; Staehler, M. D.; Matveev, V. B.; George, S.; Hutson, T. E.; Vaishampayan, U. N.; Merchan, J. R.; Eto, M.; more...
    Asia-Pacific Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Baseline health-related quality-of-life metrics among patients with testicular germ cell tumours
    Research Letter

    Gold, S. A.; Yu, R.; Jayalath, V. H.; Baky, F.; Liso, N.; Williams, B.; Tin, A. L.; Feldman, D. R.; Funt, S. A.; Vickers, A. J.; more...
    BJU International (2025)

    Fulltext@MSK | Save
  • Recommended clinical context and patient context data elements for liquid biopsy data submitted to data repositories and data commons
    Guidelines

    Grossman, R. L.; Vinson, J.; Bain, E.; Bisselou, K.; Chandan, S.; Compton, C.; Hu, J.; Johann, D. J.; Jones, F.; Jones, G.; more...
    CTS-Clinical and Translational Science (2025)

    Fulltext@MSK | Save
  • Utilization and perceptions of chaplaincy among hospitalized adults of Dharmic religions with cancer
    Journal Article

    Patel, R. V.; Bowden, J. M.; Boselli, D.; Strahley, A. E.; Gibbs, S. E. L.; Murali, K. P.; Patel, V. R.; Kotecha, R. R.; Nelson, J. E.
    Cancer (2025)

    Fulltext@MSK | Save
  • Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024
    Guidelines

    Bryce, A. H.; Agarwal, N.; Beltran, H.; Hussain, M. H.; Sartor, O.; Shore, N.; Antonarakis, E. S.; Armstrong, A. J.; Calais, J.; Carducci, M. A.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial
    Journal Article

    Morris, M. J.; de Bono, J.; Nagarajah, J.; Sartor, O.; Wei, X. X.; Nordquist, L. T.; Koshkin, V. S.; Chi, K. N.; Krause, B. J.; Herrmann, K.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial
    Journal Article

    McKay, R. R.; Xie, W.; Yang, X.; Acosta, A.; Rathkopf, D.; Laudone, V. P.; Bubley, G. J.; Einstein, D. J.; Chang, P.; Wagner, A. A.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Genomic ancestry in kidney cancer: Correlations with clinical and molecular features
    Journal Article

    Kotecha, R. R.; Knezevic, A.; Arora, K.; Bandlamudi, C.; Kuo, F.; Carlo, M. I.; Fitzgerald, K. N.; Feldman, D. R.; Shah, N. J.; Reznik, E.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Localised non-metastatic sarcomatoid renal cell carcinoma: A 31-year externally verified study
    Journal Article

    Blum, K. A.; Silagy, A. W.; Knezevic, A.; Weng, S.; Wang, A.; Mano, R.; Marcon, J.; DiNatale, R. G.; Sanchez, A.; Tickoo, S.; more...
    BJU International (2024)

    Fulltext@MSK | Save